Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.
Sørensen JB, Frank H, Palshof T. Department Oncology, Finsen Centre/National University Hospital, 9 Blegdamsvej, Copenhagen DK-2100, Denmark. jens.benn.soerensen@rh.regionh.dk

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.
Stebbing J, Powles T, McPherson K, Shamash J, Wells P, Sheaff MT, Slater S, Rudd RM, Fennell D, Steele JP. Department of Medical Oncology, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A. Department of Medical Oncology and Hematology, Humanitas Clinical Institute of Rozzano, Milan, Italy. paolo.zucali@humanitas.it

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.
Fennell DA, C Steele JP, Shamash J, Sheaff MT, Evans MT, Goonewardene TI, Nystrom ML, Gower NH, Rudd RM. Lung and Mesothelioma Unit, Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, United Kingdom. d.a.fennell@qmul.ac.uk

[Vinorelbine in patients with malignant pleural mesothelioma--a phase II study]
Ost E, Illiger HJ. PMID: 11544910 [PubMed - indexed for MEDLINE]

Phase II study of vinorelbine in patients with malignant pleural mesothelioma.
Steele JP, Shamash J, Evans MT, Gower NH, Tischkowitz MD, Rudd RM. Department of Medical Oncology, St Bartholomew's Hospital, and the London Lung Cancer Group, London, United Kingdom. j.p.steele@mds.qmw.ac.uk